Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPD

NCT02685293 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of recruitment

Conditions

COPD

Interventions

DRUG: GFF MDI (PT003)
DRUG: Placebo MDI

Sponsor

Pearl Therapeutics, Inc.